CHEK1 and cancer: On the other hand, combination of Chk1 and ATR inhibition with other DDR and signal transduction inhibitors such as drugs targeting WEE1, PARP1, or broad kinase inhibitors could potentially be better tolerated and more efficient anti-cancer treatment strategies [237,238,239,240,241,242].